Clinical Trial: Ultralow Dose PET Imaging for PSMA Expression

U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06904313) titled 'Ultralow Dose PET Imaging for PSMA Expression' on March 24.

Brief Summary: The goal of this clinical trial is to evaluate an investigational ultralow dose PET imaging technique for prostate cancer detection and monitoring. The main question it aims to answer is:

Can the investigators optimize the timing, scan duration, and image reconstruction to reduce the radiation dose 10-100 fold of the current clinical standard?

Participants will be injected with a radioactive tracer called 18F-DCFPyL and be imaged on a new type of high sensitivity PET scanner for up to 3 hours

Study Start Date: May 01

Study Type: INTERVENTIONAL

Condition:...